Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.08B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.29B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$752M |
| 4 |
Microsoft
MSFT
|
+$699M |
| 5 |
NVIDIA
NVDA
|
+$578M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$4.9B |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$986M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$951M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$794M |
| 5 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.33% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTO
2226
CTO Realty Growth
CTO
$819M
| $6.41M | ﹤0.01% |
371,186
+32,034
| +9% | +$579K |
|
2227
ATS Corp
ATS
$2B
| $6.37M | ﹤0.01% |
200,237
-373
| -0.2% | -$10.2K |
|
2228
Cogent Biosciences
COGT
$6.76B
| $6.37M | ﹤0.01% |
886,987
+60,692
| +7% | +$336K |
|
2229
Community Health Systems
CYH
$410M
| $6.36M | ﹤0.01% |
1,869,410
+456,333
| +32% | +$1.47M |
|
2230
Arcus Biosciences
RCUS
$3.69B
| $6.32M | ﹤0.01% |
776,742
+62,740
| +9% | +$536K |
|
2231
Opendoor
OPEN
$3.39B
| $6.32M | ﹤0.01% |
12,247,052
-256,086
| -2% | -$185K |
|
|
XRN
2232
Chiron Real Estate Inc
XRN
$480M
| $6.3M | ﹤0.01% |
181,941
+7,348
| +4% | +$256K |
|
2233
Grid Dynamics Holdings
GDYN
$632M
| $6.28M | ﹤0.01% |
543,872
+12,991
| +2% | +$171K |
|
|
TRTX
2234
TPG RE Finance Trust
TRTX
$610M
| $6.27M | ﹤0.01% |
812,483
+159,892
| +25% | +$1.22M |
|
2235
Spyre Therapeutics
SYRE
$9.18B
| $6.26M | ﹤0.01% |
418,503
+35,867
| +9% | +$531K |
|
|
CHCT
2236
Community Healthcare Trust
CHCT
$430M
| $6.26M | ﹤0.01% |
376,491
+19,687
| +6% | +$325K |
|
2237
Core Laboratories
CLB
$571M
| $6.23M | ﹤0.01% |
540,982
+42,992
| +9% | +$510K |
|
2238
EverQuote
EVER
$867M
| $6.23M | ﹤0.01% |
257,518
+9,646
| +4% | +$229K |
|
2239
NatWest
NWG
$76.7B
| $6.22M | ﹤0.01% |
439,910
+100,503
| +30% | +$1.33M |
|
2240
Revolve Group
RVLV
$1.69B
| $6.21M | ﹤0.01% |
309,909
-4,775
| -2% | -$96.7K |
|
2241
First Mid Bancshares
FMBH
$1.38B
| $6.21M | ﹤0.01% |
165,529
-7,941
| -5% | -$278K |
|
2242
Dine Brands
DIN
$462M
| $6.19M | ﹤0.01% |
254,231
+65,077
| +34% | +$1.5M |
|
2243
Miller Industries
MLR
$643M
| $6.18M | ﹤0.01% |
139,031
+25,298
| +22% | +$1.1M |
|
2244
PDF Solutions
PDFS
$2.19B
| $6.17M | ﹤0.01% |
288,532
+5,780
| +2% | +$109K |
|
2245
Mercantile Bank Corp
MBWM
$1.06B
| $6.17M | ﹤0.01% |
132,851
+3,966
| +3% | +$172K |
|
2246
HealthStream
HSTM
$829M
| $6.14M | ﹤0.01% |
221,995
-1,133
| -0.5% | -$33.5K |
|
2247
Enliven Therapeutics
ELVN
$4.24B
| $6.13M | ﹤0.01% |
305,660
+46,123
| +18% | +$873K |
|
2248
Adtran
ADTN
$665M
| $6.12M | ﹤0.01% |
682,069
-22,203
| -3% | -$177K |
|
2249
MGP Ingredients
MGPI
$381M
| $6.07M | ﹤0.01% |
202,622
+34,088
| +20% | +$1.01M |
|
2250
Grindr
GRND
$2.76B
| $6.05M | ﹤0.01% |
266,644
+75,437
| +39% | +$1.66M |
|
Similar funds
Charles Schwab's Q2 2025 Portfolio in Review
As of Q2 2025, Charles Schwab held 3,631 positions worth $578B, up 8.5% from $533B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab's Q2 2025 filing shows 158 new, 2,252 increased, 1,020 reduced and 137 closed positions. Its largest new stake was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B. The largest sale was Vanguard Mortgage-Backed Securities ETF, an estimated $4.9B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2025 buy was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B.
- Charles Schwab added most to Schwab Municipal Bond ETF in Q2 2025, an estimated $1.29B increase.
- Charles Schwab's biggest Q2 2025 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $4.9B.
- Charles Schwab fully exited Invesco FTSE RAFI US 1000 ETF in Q2 2025, selling an estimated $986M.
- Charles Schwab's ten largest holdings make up 23% of its $578B portfolio in Q2 2025.
- Charles Schwab opened 158 new positions and closed 137 in Q2 2025.
- Charles Schwab's portfolio value rose 8.5% quarter-over-quarter to $578B.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.